JP2022514393A5 - - Google Patents

Info

Publication number
JP2022514393A5
JP2022514393A5 JP2021535699A JP2021535699A JP2022514393A5 JP 2022514393 A5 JP2022514393 A5 JP 2022514393A5 JP 2021535699 A JP2021535699 A JP 2021535699A JP 2021535699 A JP2021535699 A JP 2021535699A JP 2022514393 A5 JP2022514393 A5 JP 2022514393A5
Authority
JP
Japan
Prior art keywords
cells
population
cell differentiation
differentiation medium
progenitor cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021535699A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022514393A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2019/051875 external-priority patent/WO2020124256A1/en
Publication of JP2022514393A publication Critical patent/JP2022514393A/ja
Publication of JP2022514393A5 publication Critical patent/JP2022514393A5/ja
Priority to JP2024194867A priority Critical patent/JP2025024025A/ja
Pending legal-status Critical Current

Links

JP2021535699A 2018-12-21 2019-12-20 ナチュラルキラー細胞に分化させるための培地および方法 Pending JP2022514393A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024194867A JP2025024025A (ja) 2018-12-21 2024-11-07 ナチュラルキラー細胞に分化させるための培地および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862783341P 2018-12-21 2018-12-21
US62/783,341 2018-12-21
PCT/CA2019/051875 WO2020124256A1 (en) 2018-12-21 2019-12-20 Media and methods for differentiating natural killer cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024194867A Division JP2025024025A (ja) 2018-12-21 2024-11-07 ナチュラルキラー細胞に分化させるための培地および方法

Publications (2)

Publication Number Publication Date
JP2022514393A JP2022514393A (ja) 2022-02-10
JP2022514393A5 true JP2022514393A5 (enExample) 2022-12-19

Family

ID=71102436

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021535699A Pending JP2022514393A (ja) 2018-12-21 2019-12-20 ナチュラルキラー細胞に分化させるための培地および方法
JP2024194867A Pending JP2025024025A (ja) 2018-12-21 2024-11-07 ナチュラルキラー細胞に分化させるための培地および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024194867A Pending JP2025024025A (ja) 2018-12-21 2024-11-07 ナチュラルキラー細胞に分化させるための培地および方法

Country Status (8)

Country Link
US (1) US20220056412A1 (enExample)
EP (1) EP3898951A4 (enExample)
JP (2) JP2022514393A (enExample)
KR (1) KR102932302B1 (enExample)
CN (1) CN113383070A (enExample)
CA (1) CA3124266A1 (enExample)
SG (1) SG11202106565WA (enExample)
WO (1) WO2020124256A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113337466B (zh) * 2021-07-13 2023-03-24 杭州原生生物科技有限公司 一种无血清nk分化培养基及其制备方法
CN113789299B (zh) * 2021-10-18 2023-03-24 新鲁细胞生物科技(海南)有限公司 一种脐血nk细胞的体外增殖培养基、体外培养试剂盒和体外培养方法
CN119137261A (zh) 2021-12-17 2024-12-13 优莫佳生物制药股份有限公司 细胞毒性先天淋巴样细胞及其用途
KR20250022800A (ko) 2022-06-10 2025-02-17 우모자 바이오파마 인코포레이티드 조작된 줄기 세포 및 그의 용도
US20260176585A1 (en) * 2022-11-07 2026-06-25 Maru Therapeutics Co., Ltd. Cultivation method for enhancing differentiation efficiency and functionality of nk cells
WO2024101863A1 (ko) * 2022-11-07 2024-05-16 마루테라퓨틱스 주식회사 줄기세포 기원 및 발현 마커에 따른 nk 세포 분화 효율 증진 방법
IL328711A (en) 2023-12-13 2026-07-01 Umoja Biopharma Inc Myeloid cells derived from engineered induced stem cells and methods for differentiating and using them
WO2026123001A2 (en) 2024-12-06 2026-06-11 Umoja Biopharma, Inc. Lineage-loci engineered cell therapy and related methods of producing and using same
WO2026123000A2 (en) 2024-12-06 2026-06-11 Umoja Biopharma, Inc. Cytokine armored engineered innate lymphoid cells and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090123442A1 (en) * 2007-11-09 2009-05-14 Avaris Ab Expanded nk cells
WO2013119118A1 (en) * 2012-02-08 2013-08-15 Ipd-Therapeutics B.V. Ex vivo nk cell differentiation from cd34+ hematopoietic cells
KR20230146101A (ko) * 2014-12-31 2023-10-18 안트로제네시스 코포레이션 천연 킬러 세포 및 그의 용도
WO2016191879A1 (en) * 2015-06-05 2016-12-08 Héma-Québec Methods for culturing and/or differentiating hematopoietic stem cells into progenitors and uses thereof
US12076342B2 (en) * 2016-04-08 2024-09-03 The Governing Council Of The University Of Toronto Method for generating progenitor t cells from stem and/or progenitor cells and use of same
US20190209618A1 (en) * 2016-04-26 2019-07-11 Mcmaster University Methods and compositions for expansion of hematopoietic stem and/or progenitor cells employing a cytochrome p450 1b1 (cyp1b1) inhibitor or a musashi-2 (msi2) activator
GB201706544D0 (en) * 2017-04-25 2017-06-07 Plasticell Ltd Method

Similar Documents

Publication Publication Date Title
JP7061961B2 (ja) 多能性幹細胞の免疫細胞への分化を誘導する方法
JP2023029655A (ja) 造血前駆体の集団および造血前駆体のための幹細胞を富化する方法
Timmermans et al. Generation of T cells from human embryonic stem cell-derived hematopoietic zones
Chen et al. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells
Slukvin Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells
JP2022078215A (ja) 多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法
JP5944885B2 (ja) 無血清条件下でのクローン性間葉先駆体及び間葉幹細胞株の作製
Nishikawa A complex linkage in the developmental pathway of endothelial and hematopoietic cells
Magnusson et al. Expansion on stromal cells preserves the undifferentiated state of human hematopoietic stem cells despite compromised reconstitution ability
Kim et al. Effective differentiation of induced pluripotent stem cells into dental cells
US20180230433A1 (en) Use of dermatopontin for maintaining hematopoietic stem and/or progenitor cells in culture
JP2025024025A (ja) ナチュラルキラー細胞に分化させるための培地および方法
Philonenko et al. Recapitulative haematopoietic development of human pluripotent stem cells in the absence of exogenous haematopoietic cytokines
Galić et al. Generation of T lineage cells from human embryonic stem cells in a feeder free system
Pievani et al. Harnessing mesenchymal stromal cells for the engineering of human hematopoietic niches
Wang et al. Hypoxia drives hematopoiesis with the enhancement of T lineage through eliciting arterial specification of hematopoietic endothelial progenitors from hESC
KR20220008894A (ko) 신경제세포 또는 각막 상피 세포의 순화 방법
CN117157388A (zh) 卵巢体细胞样细胞的制造方法及将灵长类多能干细胞分化诱导成卵巢体细胞样细胞的方法
US20260097074A1 (en) Erythroid lineages derived from pluripotent cells
Kanji et al. Plasticity and maintenance of hematopoietic stem cells during development
Konuma et al. Forced expression of the histone demethylase Fbxl10 maintains self-renewing hematopoietic stem cells
Lee et al. Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells
JP7430877B2 (ja) 造血前駆細胞マーカー
Nakamori et al. Human bone marrow stromal cells simultaneously support B and T/NK lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesis
US20070243608A1 (en) Platelet bioreactor